108 results
Blood Disorders - Markers and Differential Diagnosis Algorithm 
Acute
 • Myloid (AML) - CD13, CD33, CD34,
- T-cell - CD7 ... , CD3 Chronic ... - B-cell CD5 ... o CML - bcr-able ... o Other bcr-able
HIV Associated Infections Based on CD4 Count 

#Diagnosis #InfectiousDisease #CD4Count #HIV #AIDS #Opportunistic #Infections #OI #Table
Infections Based on CD4 ... Infections #OI #Table ... #Prophylaxis #CD4
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... #pharmacology #table
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Pharmacology #Opiates #CKD ... #Gabapentin #Table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... Improved outcomes in CKD ... #medications #table
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
community-associated CDI ... #Clostridium #Table
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
SGLT2i in HF and CKD ... SGLT2i in HF and CKD ... patients with CKD ... visualabstract #table ... #CVD #CKD
Leishmaniasis Life Cycle
1) Sandfly takes a blood meal (injects promastigote stage into the skin)
Human Stages:
2) Promastigotes
Leishmaniasis #LifeCycle ... infectiousdiseases #cdc
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
medications in CKD ... halflife #comparison #table